Pembrolizumab and Photodynamic Therapy in Previously Treated Metastatic Esophageal Squamous Cell Carcinoma

NCT05386056 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Pembrolizumab
DRUG: Sinoporphyrin Sodium
PROCEDURE: Photodynamic therapy

Sponsor

Peking University